Skin Cancer in Heart Transplant Recipients : Risk Factor Analysis and Relevance of Immunosuppressive Therapy
The DOI matches its Crossref record.
Abstract
BACKGROUND: The frequency of skin tumors of all types and specifically of squamous cell carcinoma (SCC) is increased in heart transplantation (HT), but the predisposing risk factors are controversial. METHODS AND RESULTS: We studied 300 patients (age 49+/-15 years, 258 men, mean follow-up 4.6 years, follow-up range 1 month to 12 years) who were receiving standard double (cyclosporin plus azathioprine) or triple (cyclosporin plus azathioprine plus prednisone) therapy. The first-year rejection score was calculated for endomyocardial biopsy samples (International Society for Heart and Lung Transplantation grade 0=0, 1A=1, 1B=2, 2=3, 3A=4, 3B=5, and 4=6) and used as an indirect marker of the level of immunosuppression. Multivariate analysis (Cox regression) included age at HT, sex, skin type, first-year rejection score, presence of warts and solar keratosis, lifetime sunlight exposure, and first-year cumulative dose of steroids. The incidence of skin tumors of all types increased from 15% after 5 years to 35% after 10 years after HT according to life-table analysis. Age at HT of >50 years (P:=0.03, RR=5.3), skin type II (P:=0.05, RR=2.6), rejection score of 19 (P:=0.003, RR=5.7), solar keratosis (P:=0.001, RR=6.9), and lifetime sunlight exposure of >30 000 hours (P:=0.0003, RR=7.6) were risk factors for SCC. CONCLUSIONS: Older age at HT, light skin type, solar keratosis, greater sunlight exposure, and high rejection score in the first year were independently associated with an increased risk of SCC. The progressive increase in cancer frequency during follow-up and the association with high rejection scores suggest that both the length and level of immunosuppression may be relevant. Because cumulative immunosuppressive load is cumbersome to calculate, a high rejection score in the first year may provide a useful predictor for patients at risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Cutaneous photodamage, oxidative stress, and topical antioxidant protection
Pinnell, S. R. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.16 · Cited by 544
Time-dependent bias was common in survival analyses published in leading clinical journals
van Walraven, C., Davis, D., Forster, A. J., & Wells, G. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.12.008 · Cited by 337
“02] [97] dnisone used by 1 year na [P ns]”
MethodMechanisms underlying UV-induced immune suppression
Ullrich, S. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.059 · Cited by 316
Jiyad, Z., Olsen, C. M., Burke, M. T., Isbel, N. M., & Green, A. C. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13863 · Cited by 219
“However, doses of immunosuppressant medication vary widely between graft organs, and some studies have suggested that it is dosage, rather than individual drugs, that is a significant risk factor for skin cancer (3,58,61,62).”
Background
Metadata
- Authors
- Caforio, A. L. P., Fortina, A. B., Piaserico, S., Alaibac, M., Tona, F., Feltrin, G., Pompei, E., Testolin, L., Gambino, A., Volta, S. D., Thiene, G., Casarotto, D., & Peserico, A.
- Venue
- Circulation
- Published
- 2000-11-07
- Volume
- 102
- Issue
- Supplement 3
- Pages
- III-222-III-227
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975936023
- Cited by
- 149
- References
- 0
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Skin Cancer in Heart Transplant Recipients : Risk Factor Analysis and Relevance of Immunosuppressive Therapy. https://app.cochat.ai/papers/10.1161/01.cir.102.suppl_3.iii-222
- The paper
- Caforio, A. L. P., Fortina, A. B., Piaserico, S., Alaibac, M., Tona, F., Feltrin, G., Pompei, E., Testolin, L., Gambino, A., Volta, S. D., Thiene, G., Casarotto, D., & Peserico, A. (2000). Skin Cancer in Heart Transplant Recipients : Risk Factor Analysis and Relevance of Immunosuppressive Therapy. Circulation. https://doi.org/10.1161/01.cir.102.suppl_3.iii-222
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.